SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis > Nemus Bioscience, Inc. (NMUS)

'Valeant acquired Cesamet from Eli Lilly in 2004

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
AntonChigurh Member Profile
 
Followed By 2
Posts 357
Boards Moderated 0
Alias Born 04/03/17
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 10/13/2017 4:36:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/13/2017 4:35:04 PM
MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing "InvestorsHub NewsWire" - 8/30/2017 10:29:33 PM
PotNetwork Holdings, Inc Confirmed for MJAC 2017 "InvestorsHub NewsWire" - 8/28/2017 10:43:55 AM
MJAC 2017 International Cannabis Conference - Discount Code "InvestorsHub NewsWire" - 8/25/2017 6:50:56 PM
Book your ticket now for InvestorsHubs International Cannabis Conference "InvestorsHub NewsWire" - 8/23/2017 12:50:25 PM
MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market "InvestorsHub NewsWire" - 8/22/2017 1:27:13 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 8/11/2017 5:05:36 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2017 5:00:47 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/11/2017 9:10:58 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/11/2017 9:05:23 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 5/12/2017 4:49:26 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/12/2017 4:48:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/4/2017 5:20:54 PM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 3/28/2017 4:24:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/28/2017 10:53:24 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 3/24/2017 6:01:45 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 3/23/2017 9:30:08 AM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 3/13/2017 5:29:03 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/10/2017 4:55:09 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 2/9/2017 6:01:53 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/8/2017 4:55:04 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 2/6/2017 5:12:20 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 1/20/2017 5:02:36 PM
AntonChigurh   Sunday, 09/24/17 01:18:01 AM
Re: AntonChigurh post# 2769
Post # of 2845 
'Valeant acquired Cesamet from Eli Lilly in 2004 and already sells the product in Canada, where it has about an 86% share of the cannabinoid market, accoridng to IMS data. It expects to launch Cesamet in the USA within the next few weeks.'

'Nabilone was originally developed by Eli Lilly and Company; Lilly received FDA approval in 1985 to market it, but withdrew that approval in 1989 for commercial reasons.[9] Valeant Pharmaceuticals acquired the rights from Lilly in 2004.[9] Valeant tried and failed to get the drug approved in 2005[10] and then succeeded in 2006.[9]'

Murphy CSO at VRX 2003-2006

DYODD


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist